- Vía Hispanidad, 21 - 50009 Zaragoza
- Spain | Phone: +34 976 796 562
- Email: firstname.lastname@example.org
- Contact us
- Work with us
- Privacy notices
- Cookies Policy
- Cookie Settings
- Certifications: ISO 9001:2015 · ISO 13485:2016
Araclon Biotech, a subsidiary of Grifols, is a company specialising in the research and development of methods for the early diagnosis and preventive treatment of Alzheimer’s disease.
We are pioneers in the development of assays based on the determination of amyloid peptides in plasma that help to detect early pathological changes of the disease, before the onset of symptoms.
We are developing ABvac40, an active vaccine to prevent the disease or delay the onset of symptoms.